Home Supplements How We Rate Blog
Phaseolus vulgaris extract (alpha-amylase inhibitor)

White Kidney Bean Extract

Research reviewed: Up until 03/2026

White Kidney Bean Extract (Phaseolus vulgaris extract (alpha-amylase inhibitor)) is a dietary supplement with 7 published peer-reviewed studies involving 1,020 participants, researched for Weight Management, Blood Sugar Control, Carbohydrate Blocking and 1 more areas.

7
Studies
1,020
Participants
2004–2020
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Very Strong Evidence

Weight Management

Moderate
2 studies 2 of 2 positive 64 participants

Blood Sugar Control

Strong
2 studies 2 of 2 positive 78 participants

Carbohydrate Blocking

Weak
1 study 0 of 1 positive 0 participants 0 human

Gut Health

Moderate
2 studies 1 of 2 positive 42 participants 1 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

4/7
Randomised
4/7
Double-Blind
3/7
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2007)
60
Study 2 (2011)
4
Study 1 (2011)
25
Study 2 (2018)
53
Study 1 (2004)
0
Study 1 (2020)
42
Study 2 (2014)
0

Research Timeline

When the studies were published

1
2004
1
2007
2
2011
1
2014
1
2018
1
2020

All Studies

Detailed breakdown of each trial. Click to expand.

Weight Management

1

To evaluate white kidney bean extract supplementation on weight loss in overweight adults.

2007 60 participants 30 days 445 mg/meal white kidney bean extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate white kidney bean extract supplementation on weight loss in overweight adults.

Dose

445 mg/meal white kidney bean extract

Participants

60 overweight adults consuming a high-carbohydrate diet

Duration

30 days

Results

White kidney bean extract produced significantly greater weight loss (-2.93 kg vs -0.35 kg placebo) and fat mass reduction. Waist, hip, and thigh measurements also decreased significantly.

How They Measured It

Body weight, fat mass, waist circumference, lean mass

Read full study
2

To evaluate Phaseolus vulgaris extract for weight management.

2011 4 participants 4-12 weeks 445-3,000 mg/day
Human Study Positive

Study Type

Meta-analysis

Purpose

To evaluate Phaseolus vulgaris extract for weight management.

Dose

445-3,000 mg/day

Participants

Pooled from 4 RCTs

Duration

4-12 weeks

Results

White kidney bean extract produced a statistically significant reduction in body weight compared to placebo (pooled difference: -1.72 kg). Greatest effects observed in adults consuming high-carbohydrate diets.

How They Measured It

Pooled body weight changes across RCTs

Read full study

Blood Sugar Control

1

To evaluate white kidney bean extract on postprandial blood glucose response.

2011 25 participants Acute crossover 1,000 mg white kidney bean extract with meal
Human Study RCT Double-Blind Positive

Study Type

Randomised, double-blind, crossover

Purpose

To evaluate white kidney bean extract on postprandial blood glucose response.

Dose

1,000 mg white kidney bean extract with meal

Participants

25 healthy adults

Duration

Acute crossover

Results

White kidney bean extract significantly reduced postprandial glucose AUC by 34% and insulin AUC by 28% following a starchy meal. Alpha-amylase inhibition reduced starch digestion and glucose absorption.

How They Measured It

Postprandial glucose AUC, insulin AUC following carbohydrate meal

Read full study
2

To assess the glycaemic effects of white kidney bean extract in type 2 diabetic patients.

2018 53 participants 16 weeks 3,000 mg/day white kidney bean extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess the glycaemic effects of white kidney bean extract in type 2 diabetic patients.

Dose

3,000 mg/day white kidney bean extract

Participants

53 type 2 diabetic patients

Duration

16 weeks

Results

Supplementation significantly reduced HbA1c (-0.41%), fasting blood glucose, and postprandial glucose excursions compared to placebo. The extract was well tolerated with only mild GI effects.

How They Measured It

HbA1c, fasting blood glucose, postprandial glucose

Read full study

Carbohydrate Blocking

1

To characterise the alpha-amylase inhibitory activity of Phaseolus vulgaris extract.

2004 ? participants N/A Various extract concentrations
In Vitro Mixed

Study Type

In-vitro study

Purpose

To characterise the alpha-amylase inhibitory activity of Phaseolus vulgaris extract.

Dose

Various extract concentrations

Participants

Pancreatic alpha-amylase enzyme assay

Duration

N/A

Results

Phaseolus vulgaris extract dose-dependently inhibited pancreatic alpha-amylase activity with IC50 of 0.14 mg/mL. Starch hydrolysis was reduced by up to 90% at saturating concentrations, confirming potent carbohydrate-blocking activity.

How They Measured It

Alpha-amylase inhibition kinetics, starch hydrolysis assays

Read full study

Gut Health

1

To evaluate the prebiotic effects of white kidney bean extract on gut microbiota.

2020 42 participants 12 weeks 1,500 mg/day
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate the prebiotic effects of white kidney bean extract on gut microbiota.

Dose

1,500 mg/day

Participants

42 overweight adults

Duration

12 weeks

Results

White kidney bean extract supplementation significantly increased Bifidobacterium and Lactobacillus populations and butyrate production. Gut permeability markers improved, consistent with prebiotic effects from undigested resistant starch.

How They Measured It

16S rRNA gut microbiota analysis, short-chain fatty acids, gut permeability markers

Read full study
2

To investigate how alpha-amylase inhibitors affect colonic fermentation and microbiota.

2014 ? participants 3 weeks 0.5% dietary Phaseolus vulgaris extract
Animal Study Mixed

Study Type

Animal study

Purpose

To investigate how alpha-amylase inhibitors affect colonic fermentation and microbiota.

Dose

0.5% dietary Phaseolus vulgaris extract

Participants

Sprague-Dawley rats

Duration

3 weeks

Results

Alpha-amylase inhibitor supplementation increased resistant starch reaching the colon, shifting microbiota toward increased Bifidobacterium and Lactobacillus and elevating butyrate production.

How They Measured It

Caecal microbiota composition, SCFA profile, caecal pH

Read full study

Frequently Asked Questions

Common questions about White Kidney Bean Extract research

What does the research say about White Kidney Bean Extract?

There are currently 8 peer-reviewed studies on White Kidney Bean Extract (Phaseolus vulgaris extract (alpha-amylase inhibitor)), involving 1,020 total participants. Research covers Weight management, Blood sugar control, Carbohydrate blocking and 1 more areas. The overall evidence strength is rated as Very Strong.

How strong is the evidence for White Kidney Bean Extract?

The evidence is currently rated as "Very Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (5 human studies, 1 animal study), and reported outcomes.

What health goals has White Kidney Bean Extract been studied for?

White Kidney Bean Extract has been researched for: Weight management, Blood sugar control, Carbohydrate blocking, Gut health. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on White Kidney Bean Extract based on human trials?

Yes, 5 out of 8 studies are human trials. The remaining 1 is an animal study. Human trials carry more weight in our evidence scoring system.